Results 281 to 290 of about 40,520,256 (406)
The effect of psychological empowerment on clinical nurses' thriving at work: the mediating role of voice behavior. [PDF]
Zhuang J+10 more
europepmc +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts+8 more
wiley +1 more source
The practical year: a qualitative study on stressors, resources and proposed improvements among medical students. [PDF]
Guthardt L+3 more
europepmc +1 more source
Loss‐of‐function mutations in the scaffold subunit of protein phosphatase 2A (PP2A), PPP2R1A, sensitize ovarian clear cell carcinoma to immune checkpoint blockade (ICB) by enhancing the interferon gamma response and promoting antitumor immune cell infiltration.
Matheus Henrique Dias, René Bernards
wiley +1 more source
Job stress and burnout among hospital administrative staff: a cross-sectional study. [PDF]
Lin KH, Hsu CC, Lin KY.
europepmc +1 more source
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian+10 more
wiley +1 more source
Lazy Warhol Strategies of Work Refusal in Andy Warhol’s Early Films
Gilad Reich
doaj
The interactive effects of work-family conflict and coping styles on occupational fatigue among endoscopy nurses: a cross-sectional study. [PDF]
Zeng Z+6 more
europepmc +1 more source
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga+8 more
wiley +1 more source